SarcopeniaNCT05122104
Evaluation of Sarcopenia-Related Malnutrition in Older Adults
An observational study of Sarcopenia and Malnutrition, run by Istanbul Medeniyet University at 1 site in Turkey (Türkiye).
Trial summary
Sarcopenia and malnutrition are two geriatric syndromes that are frequently seen in the elderly and have multifactorial etiology and severe clinical effects. However, the results vary widely due to the many methods and criteria used in the diagnosis and prevalence rates of both syndromes. Read more about this study
- Who is it for?
- Ages 65 years and olderHealthy volunteers can take part
- Conditions the study is for
- Sarcopenia, Malnutrition
- How many people
- 590 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Nov 2021to 16 Feb 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- Healthy volunteers accepted
- Older adult
Study population: community dwelling older adults
Who may be able to join
- To get a score of 21 and above in the Mini-Mental State Examination
- To be able to walk independently or with the help of a device (cane, etc.)
Who cannot join
- Individuals with a serious orthopedic (advanced hip or knee arthrosis, etc.) or neurologic conditions that may affect ambulation
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Ümraniye Training and research hospital
Istanbul
About this study
Official title: Evaluation of Sarcopenia-Related Malnutrition in Older Adults According to GLIM (Global
Sarcopenia and malnutrition are two geriatric syndromes that are frequently seen in the elderly and have multifactorial etiology and severe clinical effects. However, the results vary widely due to the many methods and criteria used in the diagnosis and prevalence rates of both syndromes. In this study, it is aimed to investigate the relationship between the GLIM (Global Leadership Initiative on Malnutrition) criteria and various sarcopenia levels, which are newly defined worldwide and have the widest spectrum so far in describing malnutrition.
- Conditions
- Sarcopenia, Malnutrition
- Medical subject headings
- Sarcopenia, Malnutrition
What is being measured
The primary outcome is the main question the study is designed to answer.
Malnutrition diagnosis according to GLIM criteria
Malnutrition diagnosis according to GLIM criteria
Measured: 30 minutes
Secondary outcomes (1)
Sarcopenia diagnosis according to the European Working Group on Sarcopenia in Older People (EWGSOP)
Sarcopenia diagnosis
Measured: 30 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Nov 2021
- Study start1 Nov 2021
- Primary completion1 Feb 2024
- Study completion16 Feb 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for SarcopeniaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 590 participants (actual)
Sponsor and investigators
- Lead sponsor
- Istanbul Medeniyet University
- Sponsor type
- University, hospital or other
- Collaborators
- Umraniye Education and Research Hospital
- Responsible party
- Principal investigator, Esma Nur KOLBAŞI, Istanbul Medeniyet University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05122104
- Sponsor's protocol ID
- IstanbulMU54
- Status last verified
- Jun 2024
- First submitted
- 4 Nov 2021
- Last updated
- 21 Jun 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Demirdag F, Kolbasi EN, Yildiz Guler K. The association between sarcopenic obesity and malnutrition in community-dwelling older adults. Age Ageing. 2025 Feb 2;54(2):afaf040. doi: 10.1093/ageing/afaf040.
PubMed 40036320
Study at a glance
From the registry record, last updated by the sponsor on 21 Jun 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of Sarcopenia-Related Malnutrition in Older Adults According to GLIM (Global
- ClinicalTrials.gov ID
- NCT05122104
- Acronym / sponsor ID
- IstanbulMU54
- Conditions
- Sarcopenia, Malnutrition
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 590 participants (actual)
- Lead sponsor
- Istanbul Medeniyet UniversityUniversity, hospital or other
- Collaborators
- Umraniye Education and Research Hospital
- Study start
- 1 Nov 2021 (actual)
- Primary completion
- 1 Feb 2024 (actual)
- Study completion
- 16 Feb 2024 (actual)
- First posted
- 16 Nov 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Sarcopenia and malnutrition are two geriatric syndromes that are frequently seen in the elderly and have multifactorial etiology and severe clinical effects. However, the results vary widely due to the many methods and criteria used in the diagnosis and prevalence rates of both syndromes. In this study, it is aimed to investigate the relationship between the GLIM (Global Leadership Initiative on Malnutrition) criteria and various sarcopenia levels, which are newly defined worldwide and have the widest spectrum so far in describing malnutrition.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Older adult
- Study population
- community dwelling older adults
Key inclusion criteria (2 listed)
- To get a score of 21 and above in the Mini-Mental State Examination
- To be able to walk independently or with the help of a device (cane, etc.)
Key exclusion criteria (1 listed)
- Individuals with a serious orthopedic (advanced hip or knee arthrosis, etc.) or neurologic conditions that may affect ambulation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Malnutrition diagnosis according to GLIM criteria
Time frame: 30 minutes
Malnutrition diagnosis according to GLIM criteria
1 secondary outcome
Sarcopenia diagnosis according to the European Working Group on Sarcopenia in Older People (EWGSOP)
Time frame: 30 minutes
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Jun 2024.
- Derived from this study: PubMed 40036320Demirdag F, Kolbasi EN, Yildiz Guler K. The association between sarcopenic obesity and malnutrition in community-dwelling older adults. Age Ageing. 2025 Feb 2;54(2):afaf040. doi: 10.1093/ageing/afaf040.
- Individual participant dataSharing planned: No
Related trials for Sarcopenia
Enrolling by invitation
Online Exercise Program for Transplant Patients: A Pilot Study
Kidney Transplantation, Physical Function
Not yet recruitingPhase 2
A Study of Bimagrumab in Participants With HFpEF
Heart Failure, Diastolic, Diastolic Heart Failure
Not yet recruiting
The Aim of the Study is to Decipher the Alterations in Signalling Pathways of Skeletal Muscle Stem Cells (Satellite Cells (SCs)) in Individuals With COPD, as Well as to Examine the Effect of Exercise Training on SCs.
COPD (Chronic Obstructive Pulmonary Disease), Sarcopenia in Elderly
Not yet recruitingPhase 2
MF-300 for Treatment of Age-Related Sarcopenia
Sarcopenia in Elderly
Not yet recruitingObservational study
Validation of Uzbek SARC-F and IPAQ-SF Questionnaires in Adults With and Without Hypothyroidism
Hypothyroidism, Psychometrics
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Sarcopenia and Malnutrition, run by Istanbul Medeniyet University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Malnutrition diagnosis according to GLIM criteria (time frame: 30 minutes). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05122104, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jun 2024.